Literature DB >> 18269919

The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1.

Stacy M Alvares1, Clarence A Dunn, Tod A Brown, Elizabeth E Wayner, William G Carter.   

Abstract

Cell adhesion to the extracellular matrix (ECM) via integrin adhesion receptors initiates signaling cascades leading to changes in cell behavior. While integrin clustering is necessary to initiate cell attachment to the matrix, additional membrane components are necessary to mediate the transmembrane signals and the cell adhesion response that alter downstream cell behavior. Many of these signaling components reside in glycosphingolipid-rich and cholesterol-rich membrane domains such as Tetraspanin Enriched Microdomains (TEMs)/Glycosynapse 3 and Detergent-Resistant Microdomains (DRMs), also known as lipid rafts. In the following article, we will review examples of how components in these membrane microdomains modulate integrin adhesion after initial attachment to the ECM. Additionally, we will present data on a novel adhesion-responsive transmembrane glycoprotein Gp140/CUB Domain Containing Protein 1, which clusters in epithelial cell-cell contacts. Gp140 can then be phosphorylated by Src Family Kinases at tyrosine 734 in response to outside-in signals-possibly through interactions involving the extracellular CUB domains. Data presented here suggests that outside-in signals through Gp140 in cell-cell contacts assemble membrane clusters that associate with membrane microdomains to recruit and activate SFKs. Active SFKs then mediate phosphorylation of Gp140, SFK and PKCdelta with Gp140 acting as a transmembrane scaffold for these kinases. We propose that the clustering of Gp140 and signaling components in membrane microdomains in cell-cell contacts contributes to changes in cell behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269919      PMCID: PMC4975934          DOI: 10.1016/j.bbagen.2008.01.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  53 in total

1.  Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins.

Authors:  X A Zhang; A L Bontrager; M E Hemler
Journal:  J Biol Chem       Date:  2001-04-26       Impact factor: 5.157

2.  Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.

Authors:  H Kropshofer; S Spindeldreher; T A Röhn; N Platania; C Grygar; N Daniel; A Wölpl; H Langen; V Horejsi; A B Vogt
Journal:  Nat Immunol       Date:  2001-12-17       Impact factor: 25.606

3.  Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.

Authors:  Magali André; Jean-Pierre Le Caer; Céline Greco; Sébastien Planchon; Wassim El Nemer; Claude Boucheix; Eric Rubinstein; Julia Chamot-Rooke; François Le Naour
Journal:  Proteomics       Date:  2006-03       Impact factor: 3.984

4.  Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes.

Authors:  P H Jones; L A Bishop; F M Watt
Journal:  Cell Adhes Commun       Date:  1996-11

5.  Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation.

Authors:  A R Shaw; A Domanska; A Mak; A Gilchrist; K Dobler; L Visser; S Poppema; L Fliegel; M Letarte; B J Willett
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

6.  Monoclonal mouse antibodies raised against human lung carcinoma.

Authors:  I Hellström; D Horn; P Linsley; J P Brown; V Brankovan; K E Hellström
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

7.  Integrins regulate Rac targeting by internalization of membrane domains.

Authors:  Miguel A del Pozo; Nazilla B Alderson; William B Kiosses; Hui-Hsien Chiang; Richard G W Anderson; Martin A Schwartz
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

8.  CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.

Authors:  Takamasa Uekita; Lin Jia; Mako Narisawa-Saito; Jun Yokota; Tohru Kiyono; Ryuichi Sakai
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin.

Authors:  W G Carter; H Rauvala; S I Hakomori
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539

10.  Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function.

Authors:  Rebecca L Berdeaux; Begoña Díaz; Lomi Kim; G Steven Martin
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

View more
  21 in total

1.  Phase-field model for the morphology of monolayer lipid domains.

Authors:  F Campelo; A Cruz; J Pérez-Gil; L Vázquez; A Hernández-Machado
Journal:  Eur Phys J E Soft Matter       Date:  2012-06-21       Impact factor: 1.890

2.  The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Authors:  C H Benes; G Poulogiannis; L C Cantley; S P Soltoff
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

3.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

4.  Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.

Authors:  Gwendlyn Kollmorgen; Gerhard Niederfellner; Alexander Lifke; Gloria J Spohn; Natascha Rieder; Suzana Vega Harring; Frieder Bauss; Helmut Burtscher; Reiner Lammers; Birgit Bossenmaier
Journal:  Mol Oncol       Date:  2013-09-03       Impact factor: 6.603

5.  Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Authors:  Y He; A C Wu; B S Harrington; C M Davies; S J Wallace; M N Adams; J S Palmer; D K Roche; B G Hollier; T F Westbrook; H Hamidi; G E Konecny; B Winterhoff; N P Chetty; A J Crandon; N B Oliveira; C M Shannon; A V Tinker; C B Gilks; J I Coward; J W Lumley; L C Perrin; J E Armes; J D Hooper
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

6.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

7.  Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.

Authors:  Andreas Wortmann; Yaowu He; Melinda E Christensen; Mayla Linn; John W Lumley; Pamela M Pollock; Nigel J Waterhouse; John D Hooper
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

8.  Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Authors:  B Casar; Y He; M Iconomou; J D Hooper; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

9.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

10.  Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.

Authors:  Elena I Deryugina; Erin M Conn; Andreas Wortmann; Juneth J Partridge; Tatyana A Kupriyanova; Veronica C Ardi; John D Hooper; James P Quigley
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.